Gensingen, Germany

Michael Wiese


Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2010-2025

Loading Chart...
2 patents (USPTO):

Title: Michael Wiese: Innovator in Glycine Transport Inhibitors and Metathesis Processes.

Introduction

Michael Wiese is a notable inventor based in Gensingen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of processes related to glycine transport inhibitors and metathesis reactions. With a total of 2 patents, Wiese's work showcases his innovative approach to solving complex chemical challenges.

Latest Patents

Wiese's latest patents include a process for reworking a crystalline form of a glycine transport inhibitor. This invention describes a method for reworking a crystallization product that involves drying and homogenization. The crystallization product is a complex crystalline compound, specifically designed to enhance the efficacy of glycine transport inhibition. Another significant patent is for a process for continuous ruthenium-catalysed metathesis. This invention focuses on carrying out metathesis reactions continuously using a ruthenium-containing catalyst, which streamlines the process and improves efficiency.

Career Highlights

Michael Wiese is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to explore innovative solutions in drug development and chemical processes. Wiese's expertise in chemistry and his inventive spirit have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Wiese has collaborated with esteemed colleagues such as Thomas Herweck and Albrecht Jacobi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Michael Wiese's contributions to the field of chemistry through his patents and collaborative efforts highlight his role as an influential inventor. His innovative processes for glycine transport inhibitors and metathesis reactions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…